The global Meso Scale Discovery (MSD) Assay Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.

From a downstream perspective, Pharmaceutical Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Meso Scale Discovery (MSD) Assay Services leading manufacturers including Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited, Alcyomics Ltd, IMMUNOLOGIX, etc., dominate supply; the top five capture approximately % of global revenue, with Chimera Biotec leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Meso Scale Discovery (MSD) Assay Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Meso Scale Discovery (MSD) Assay Services Market Report

Report Metric	Details
Report Name	Meso Scale Discovery (MSD) Assay Services Market
Segment by Type	S-Plex Technology V-Plex Technology Other
Segment by Application	Pharmaceutical Research Clinical Diagnostics Biomarker Discovery Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited, Alcyomics Ltd, IMMUNOLOGIX, Novogene, Guidon Pharmaceutics, MEDx Translational Medicine Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Meso Scale Discovery (MSD) Assay Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Meso Scale Discovery (MSD) Assay Services Market report?

Ans: The main players in the Meso Scale Discovery (MSD) Assay Services Market are Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited, Alcyomics Ltd, IMMUNOLOGIX, Novogene, Guidon Pharmaceutics, MEDx Translational Medicine Co., Ltd

What are the Application segmentation covered in the Meso Scale Discovery (MSD) Assay Services Market report?

Ans: The Applications covered in the Meso Scale Discovery (MSD) Assay Services Market report are Pharmaceutical Research, Clinical Diagnostics, Biomarker Discovery, Others

What are the Type segmentation covered in the Meso Scale Discovery (MSD) Assay Services Market report?

Ans: The Types covered in the Meso Scale Discovery (MSD) Assay Services Market report are S-Plex Technology, V-Plex Technology, Other

1 Study Coverage

1.1 Introduction to Meso Scale Discovery (MSD) Assay Services: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 S-Plex Technology

1.2.3 V-Plex Technology

1.2.4 Other

1.3 Market Segmentation by Application

1.3.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Research

1.3.3 Clinical Diagnostics

1.3.4 Biomarker Discovery

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Meso Scale Discovery (MSD) Assay Services Revenue Estimates and Forecasts 2020-2031

2.2 Global Meso Scale Discovery (MSD) Assay Services Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Meso Scale Discovery (MSD) Assay Services Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Meso Scale Discovery (MSD) Assay Services Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 S-Plex Technology Market Size by Players

3.3.2 V-Plex Technology Market Size by Players

3.3.3 Other Market Size by Players

3.4 Global Meso Scale Discovery (MSD) Assay Services Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Meso Scale Discovery (MSD) Assay Services Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Meso Scale Discovery (MSD) Assay Services Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Meso Scale Discovery (MSD) Assay Services Market Size by Type (2020-2031)

6.4 North America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Meso Scale Discovery (MSD) Assay Services Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Type (2020-2031)

7.4 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Type (2020-2031)

8.4 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Type (2020-2031)

9.4 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Type (2020-2031)

10.4 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Chimera Biotec

11.1.1 Chimera Biotec Corporation Information

11.1.2 Chimera Biotec Business Overview

11.1.3 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.1.4 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.1.5 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2024

11.1.6 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2024

11.1.7 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2024

11.1.8 Chimera Biotec Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.1.9 Chimera Biotec Recent Developments

11.2 Reaction Biology

11.2.1 Reaction Biology Corporation Information

11.2.2 Reaction Biology Business Overview

11.2.3 Reaction Biology Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.2.4 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.2.5 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2024

11.2.6 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2024

11.2.7 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2024

11.2.8 Reaction Biology Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.2.9 Reaction Biology Recent Developments

11.3 NorthEast BioAnalytical Laboratories LLC

11.3.1 NorthEast BioAnalytical Laboratories LLC Corporation Information

11.3.2 NorthEast BioAnalytical Laboratories LLC Business Overview

11.3.3 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.3.4 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.3.5 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2024

11.3.6 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2024

11.3.7 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2024

11.3.8 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.3.9 NorthEast BioAnalytical Laboratories LLC Recent Developments

11.4 Creative Proteomics

11.4.1 Creative Proteomics Corporation Information

11.4.2 Creative Proteomics Business Overview

11.4.3 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.4.4 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.4.5 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2024

11.4.6 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2024

11.4.7 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2024

11.4.8 Creative Proteomics Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.4.9 Creative Proteomics Recent Developments

11.5 Pestka Biomedical Laboratories, Inc

11.5.1 Pestka Biomedical Laboratories, Inc Corporation Information

11.5.2 Pestka Biomedical Laboratories, Inc Business Overview

11.5.3 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.5.4 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.5.5 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2024

11.5.6 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2024

11.5.7 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2024

11.5.8 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.5.9 Pestka Biomedical Laboratories, Inc Recent Developments

11.6 Precision Medicine Group, LLC

11.6.1 Precision Medicine Group, LLC Corporation Information

11.6.2 Precision Medicine Group, LLC Business Overview

11.6.3 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.6.4 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.6.5 Precision Medicine Group, LLC Recent Developments

11.7 CellCarta

11.7.1 CellCarta Corporation Information

11.7.2 CellCarta Business Overview

11.7.3 CellCarta Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.7.4 CellCarta Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.7.5 CellCarta Recent Developments

11.8 ImmunoDiagnostics Limited

11.8.1 ImmunoDiagnostics Limited Corporation Information

11.8.2 ImmunoDiagnostics Limited Business Overview

11.8.3 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.8.4 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.8.5 ImmunoDiagnostics Limited Recent Developments

11.9 Alcyomics Ltd

11.9.1 Alcyomics Ltd Corporation Information

11.9.2 Alcyomics Ltd Business Overview

11.9.3 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.9.4 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.9.5 Alcyomics Ltd Recent Developments

11.10 IMMUNOLOGIX

11.10.1 IMMUNOLOGIX Corporation Information

11.10.2 IMMUNOLOGIX Business Overview

11.10.3 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.10.4 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Novogene

11.11.1 Novogene Corporation Information

11.11.2 Novogene Business Overview

11.11.3 Novogene Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.11.4 Novogene Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.11.5 Novogene Recent Developments

11.12 Guidon Pharmaceutics

11.12.1 Guidon Pharmaceutics Corporation Information

11.12.2 Guidon Pharmaceutics Business Overview

11.12.3 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.12.4 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.12.5 Guidon Pharmaceutics Recent Developments

11.13 MEDx Translational Medicine Co., Ltd

11.13.1 MEDx Translational Medicine Co., Ltd Corporation Information

11.13.2 MEDx Translational Medicine Co., Ltd Business Overview

11.13.3 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.13.4 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2020-2025)

11.13.5 MEDx Translational Medicine Co., Ltd Recent Developments

12 Meso Scale Discovery (MSD) Assay ServicesIndustry Chain Analysis

12.1 Meso Scale Discovery (MSD) Assay Services Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Meso Scale Discovery (MSD) Assay Services Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Meso Scale Discovery (MSD) Assay Services Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

MSD

Chimera Biotec

Reaction Biology

NorthEast BioAnalytical Laboratories LLC.

Creative Proteomics

Pestka Biomedical Laboratories, Inc.

Precision Medicine Group, LLC

MEDx Translational Medicine Co., Ltd

List of Tables

Table 1. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Meso Scale Discovery (MSD) Assay Services Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Meso Scale Discovery (MSD) Assay Services Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Meso Scale Discovery (MSD) Assay Services Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Meso Scale Discovery (MSD) Assay Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meso Scale Discovery (MSD) Assay Services as of 2024)

Table 11. Global Meso Scale Discovery (MSD) Assay Services Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Meso Scale Discovery (MSD) Assay Services Companies Headquarters

Table 13. Global Meso Scale Discovery (MSD) Assay Services Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Meso Scale Discovery (MSD) Assay Services Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Meso Scale Discovery (MSD) Assay Services Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Meso Scale Discovery (MSD) Assay Services Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Meso Scale Discovery (MSD) Assay Services Revenue by Application (2026-2031) & (US$ Million)

Table 21. Meso Scale Discovery (MSD) Assay Services High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers

Table 25. North America Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers

Table 27. Europe Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Meso Scale Discovery (MSD) Assay Services Investment Opportunities and Key Challenges

Table 31. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Chimera Biotec Corporation Information

Table 35. Chimera Biotec Description and Major Businesses

Table 36. Chimera Biotec Product Features and Attributes

Table 37. Chimera Biotec Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Chimera Biotec Revenue Proportion by Product in 2024

Table 39. Chimera Biotec Revenue Proportion by Application in 2024

Table 40. Chimera Biotec Revenue Proportion by Geographic Area in 2024

Table 41. Chimera Biotec Meso Scale Discovery (MSD) Assay Services SWOT Analysis

Table 42. Chimera Biotec Recent Developments

Table 43. Reaction Biology Corporation Information

Table 44. Reaction Biology Description and Major Businesses

Table 45. Reaction Biology Product Features and Attributes

Table 46. Reaction Biology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Reaction Biology Revenue Proportion by Product in 2024

Table 48. Reaction Biology Revenue Proportion by Application in 2024

Table 49. Reaction Biology Revenue Proportion by Geographic Area in 2024

Table 50. Reaction Biology Meso Scale Discovery (MSD) Assay Services SWOT Analysis

Table 51. Reaction Biology Recent Developments

Table 52. NorthEast BioAnalytical Laboratories LLC Corporation Information

Table 53. NorthEast BioAnalytical Laboratories LLC Description and Major Businesses

Table 54. NorthEast BioAnalytical Laboratories LLC Product Features and Attributes

Table 55. NorthEast BioAnalytical Laboratories LLC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Product in 2024

Table 57. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Application in 2024

Table 58. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Geographic Area in 2024

Table 59. NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services SWOT Analysis

Table 60. NorthEast BioAnalytical Laboratories LLC Recent Developments

Table 61. Creative Proteomics Corporation Information

Table 62. Creative Proteomics Description and Major Businesses

Table 63. Creative Proteomics Product Features and Attributes

Table 64. Creative Proteomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Creative Proteomics Revenue Proportion by Product in 2024

Table 66. Creative Proteomics Revenue Proportion by Application in 2024

Table 67. Creative Proteomics Revenue Proportion by Geographic Area in 2024

Table 68. Creative Proteomics Meso Scale Discovery (MSD) Assay Services SWOT Analysis

Table 69. Creative Proteomics Recent Developments

Table 70. Pestka Biomedical Laboratories, Inc Corporation Information

Table 71. Pestka Biomedical Laboratories, Inc Description and Major Businesses

Table 72. Pestka Biomedical Laboratories, Inc Product Features and Attributes

Table 73. Pestka Biomedical Laboratories, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Pestka Biomedical Laboratories, Inc Revenue Proportion by Product in 2024

Table 75. Pestka Biomedical Laboratories, Inc Revenue Proportion by Application in 2024

Table 76. Pestka Biomedical Laboratories, Inc Revenue Proportion by Geographic Area in 2024

Table 77. Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services SWOT Analysis

Table 78. Pestka Biomedical Laboratories, Inc Recent Developments

Table 79. Precision Medicine Group, LLC Corporation Information

Table 80. Precision Medicine Group, LLC Description and Major Businesses

Table 81. Precision Medicine Group, LLC Product Features and Attributes

Table 82. Precision Medicine Group, LLC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Precision Medicine Group, LLC Recent Developments

Table 84. CellCarta Corporation Information

Table 85. CellCarta Description and Major Businesses

Table 86. CellCarta Product Features and Attributes

Table 87. CellCarta Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. CellCarta Recent Developments

Table 89. ImmunoDiagnostics Limited Corporation Information

Table 90. ImmunoDiagnostics Limited Description and Major Businesses

Table 91. ImmunoDiagnostics Limited Product Features and Attributes

Table 92. ImmunoDiagnostics Limited Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. ImmunoDiagnostics Limited Recent Developments

Table 94. Alcyomics Ltd Corporation Information

Table 95. Alcyomics Ltd Description and Major Businesses

Table 96. Alcyomics Ltd Product Features and Attributes

Table 97. Alcyomics Ltd Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Alcyomics Ltd Recent Developments

Table 99. IMMUNOLOGIX Corporation Information

Table 100. IMMUNOLOGIX Description and Major Businesses

Table 101. IMMUNOLOGIX Product Features and Attributes

Table 102. IMMUNOLOGIX Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. IMMUNOLOGIX Recent Developments

Table 104. Novogene Corporation Information

Table 105. Novogene Description and Major Businesses

Table 106. Novogene Product Features and Attributes

Table 107. Novogene Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Novogene Recent Developments

Table 109. Guidon Pharmaceutics Corporation Information

Table 110. Guidon Pharmaceutics Description and Major Businesses

Table 111. Guidon Pharmaceutics Product Features and Attributes

Table 112. Guidon Pharmaceutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Guidon Pharmaceutics Recent Developments

Table 114. MEDx Translational Medicine Co., Ltd Corporation Information

Table 115. MEDx Translational Medicine Co., Ltd Description and Major Businesses

Table 116. MEDx Translational Medicine Co., Ltd Product Features and Attributes

Table 117. MEDx Translational Medicine Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. MEDx Translational Medicine Co., Ltd Recent Developments

Table 119. Raw Materials Key Suppliers

Table 120. Distributors List

Table 121. Market Trends and Market Evolution

Table 122. Market Drivers and Opportunities

Table 123. Market Challenges, Risks, and Restraints

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Meso Scale Discovery (MSD) Assay Services Product Picture

Figure 2. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. S-Plex Technology Product Picture

Figure 4. V-Plex Technology Product Picture

Figure 5. Other Product Picture

Figure 6. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Pharmaceutical Research

Figure 8. Clinical Diagnostics

Figure 9. Biomarker Discovery

Figure 10. Others

Figure 11. Meso Scale Discovery (MSD) Assay Services Report Years Considered

Figure 12. Global Meso Scale Discovery (MSD) Assay Services Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 14. Global Meso Scale Discovery (MSD) Assay Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share by Region (2020-2031)

Figure 16. Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share Ranking (2024)

Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 18. S-Plex Technology Revenue Market Share by Player in 2024

Figure 19. V-Plex Technology Revenue Market Share by Player in 2024

Figure 20. Other Revenue Market Share by Player in 2024

Figure 21. Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share by Type (2020-2031)

Figure 22. Global Meso Scale Discovery (MSD) Assay Services Revenue Market Share by Application (2020-2031)

Figure 23. North America Meso Scale Discovery (MSD) Assay Services Revenue YoY (2020-2031) & (US$ Million)

Figure 24. North America Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2024

Figure 25. North America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Type (2020 - 2031)

Figure 26. North America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2020-2031)

Figure 27. US Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 28. Canada Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 29. Mexico Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 30. Europe Meso Scale Discovery (MSD) Assay Services Revenue YoY (2020-2031) & (US$ Million)

Figure 31. Europe Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2024

Figure 32. Europe Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Type (2020-2031)

Figure 33. Europe Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2020-2031)

Figure 34. Germany Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 35. France Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 36. U.K. Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 37. Italy Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 38. Russia Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Top 8 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2024

Figure 41. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Type (2020-2031)

Figure 42. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2020-2031)

Figure 43. Indonesia Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 44. Japan Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 45. South Korea Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 46. Australia Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 47. India Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 48. Indonesia Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 49. Vietnam Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 50. Malaysia Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 51. Philippines Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 52. Singapore Meso Scale Discovery (MSD) Assay Services Revenue (2020-2031) & (US$ Million)

Figure 53. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Central and South America Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2024

Figure 55. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Type (2020-2031)

Figure 56. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2020-2031)

Figure 57. Brazil Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 58. Argentina Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 59. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Middle East and Africa Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2024

Figure 61. South America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Type (2020-2031)

Figure 62. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2020-2031)

Figure 63. GCC Countries Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 64. Israel Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 65. Egypt Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 66. South Africa Meso Scale Discovery (MSD) Assay Services Revenue (2020-2025) & (US$ Million)

Figure 67. Meso Scale Discovery (MSD) Assay Services Industry Chain Mapping

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions